CIMA Labs Catches The Eye Of Another As Cephalon Outbids AaiPharma
This article was originally published in The Tan Sheet
Executive Summary
AaiPharma's refusal to increase its offer for fast-dissolving drug delivery technology maker CIMA Labs puts into serious jeopardy their proposed merger in the face of a rival bid from Rx drug company Cephalon